20-19681916-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_020689.4(SLC24A3):c.826G>A(p.Val276Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,614,178 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020689.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC24A3 | NM_020689.4 | c.826G>A | p.Val276Ile | missense_variant | 10/17 | ENST00000328041.11 | NP_065740.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC24A3 | ENST00000328041.11 | c.826G>A | p.Val276Ile | missense_variant | 10/17 | 1 | NM_020689.4 | ENSP00000333519.5 |
Frequencies
GnomAD3 genomes AF: 0.000979 AC: 149AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000748 AC: 188AN: 251486Hom.: 0 AF XY: 0.000743 AC XY: 101AN XY: 135916
GnomAD4 exome AF: 0.00151 AC: 2212AN: 1461882Hom.: 11 Cov.: 31 AF XY: 0.00145 AC XY: 1055AN XY: 727242
GnomAD4 genome AF: 0.000978 AC: 149AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000873 AC XY: 65AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.826G>A (p.V276I) alteration is located in exon 10 (coding exon 10) of the SLC24A3 gene. This alteration results from a G to A substitution at nucleotide position 826, causing the valine (V) at amino acid position 276 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at